超七成主动权益类基金获正收益 机构看好后市结构性机会

Core Viewpoint - The performance of active equity funds has shown a positive trend in the first half of the year, with over 70% achieving positive returns, particularly in the pharmaceutical and North Exchange sectors [1][2]. Group 1: Fund Performance - As of June 26, 2023, 6085 out of 7881 equity and mixed-asset funds reported positive returns, representing over 70% [2]. - The leading pharmaceutical fund, Huazhong Pharmaceutical Bio A, achieved a return of 75.91%, while several others exceeded 50% [2]. - North Exchange-themed funds also performed well, with the CITIC Construction North Exchange Select Fund yielding 80.71% [2]. Group 2: Market Outlook - Institutions maintain a cautiously optimistic view for the second half of the year, expecting a continuation of structural market characteristics [1][3]. - Key sectors for investment include technology, new consumption, and innovative pharmaceuticals, which are seen as having strong growth potential [1][4]. - The A-share market is anticipated to exhibit clear structural features, with the index likely oscillating around a central point [3]. Group 3: Investment Strategies - Investors are advised to focus on low-entry opportunities rather than chasing high prices, given the rapid rotation of market styles [4][5]. - Specific areas of interest include technology, new consumption, stable dividend stocks, and sectors benefiting from policy support [5]. - The expected policy measures are likely to positively influence investor sentiment and the equity market [5].